EHS
EHS

New patent for Hoffmann-la Roche drug ALECENSA – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Hoffmann-la Roche drug ALECENSA


Annual Drug Patent Expirations for ALECENSA

Alecensa is a drug marketed by Hoffmann-la Roche and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has one hundred and ten patent family members in thirty-eight countries.

The generic ingredient in ALECENSA is alectinib hydrochloride. One supplier is listed for this compound. Additional details are available on the alectinib hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Hoffmann-la Roche drug ALECENSA



Source link

EHS
Back to top button